Molecular Profiles Introduces New Nanoscale Predictive Analytical Screening Solution for APIs
Molecular Profiles, provider of contract research services to the pharmaceutical, biopharmaceutical and biomedical sectors, announcds the latest addition to its comprehensive nanoscale analytical services offering, nanoPASS (nanoscale Predictive Analytical Screening Solution). According to the company, this new service platform is a comprehensive suite of complementary analytical techniques designed to optimise solid state selection of APIs and provide further insight into the formulation of APIs and excipients.
"The introduction of this novel service platform further demonstrates our dedication to providing a high quality and reliable extension to the R&D capabilities within pharmaceutical companies," comments Dr. Nikin Patel, CEO, Molecular Profiles. "Our team of specialised, experienced scientists will be building upon this platform to develop an extended range of service offerings intended to provide our customers with even more clarity and choice."
Most read news
Other news from the department business & finance

Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.